Clinical Trial Update: A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of PF 04494700 in mild to moderate Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PF-04494700

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED